Stock market today: Live updates
A trader works on the floor of the New York Stock Exchange on Oct. 20, 2023. Michael Nagle | Bloomberg | Getty Images U.S. stock futures were flat Monday night …
Pfizer Inc
These stocks have earnings momentum heading into reports this week
Another chunk of companies are set to report this week, and analysts think earnings are on their side. About 50% of S & P 500 companies have reported earnings for …
Are things about to get more difficult?
Up from No. 13 in 2022, Minneapolis, Minnesota ranked as the No. 2 most neighborly city in America. S. Greg Panosian | E+ | Getty Images This report is from …
CNBC Daily Open: The perfect storm
NEW YORK, NEW YORK – JUNE 03: People walk by the New York Stock Exchange (NYSE) at the start of the trading day on June 03, 2022 in New York …
Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end
Novo Nordisk and Eli Lilly reign over the anti-obesity drug market, and don’t expect this duopoly to end soon, analysts say. But other companies — both big and small — …
Jamie Dimon’s trades show the benefit of tracking insider buying, selling
For the first time in nearly two decades running JPMorgan Chase, CEO Jamie Dimon will voluntarily sell stock in the bank. The disclosure, in a securities filing Friday, detailed next …
Merck (MRK) Q3 earnings report 2023
Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations …
Pfizer combination Covid, flu vaccine shows positive trial data
CFOTO | Future Publishing | Getty Images Pfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months …
Bristol Myers Squibb (BMY) Q3 earnings report 2023
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid …
GSK RSV vaccine shows potential to protect adults 50 to 59
A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial …